Literature DB >> 9239670

Recombinant human zona pellucida glycoprotein 3 induces calcium influx and acrosome reaction in human spermatozoa.

I A Brewis1, R Clayton, C L Barratt, D P Hornby, H D Moore.   

Abstract

Recombinant human ZP3 (rhuZP3) generated by Chinese hamster ovary cells transfected with a plasmid containing human ZP3 cDNA was used to study the acrosome reaction (AR) and intracellular calcium fluxes in capacitated human spermatozoa. Conditioned medium containing rhuZP3 significantly induced the AR (P < or = 0.005) in 59.4 +/- 4.7% of spermatozoa (control = 8.5 +/- 3.1%) and caused complete acrosomal loss in a further 17.2 +/- 3.8% of cells (control = 3.7 +/- 0.7%; mean +/- SEM, n = 5). Sperm motility was not affected and acrosomal exocytosis in response to rhuZP3 was also shown to be time-dependent. Basal concentrations of sperm intracellular calcium were measured (82 +/- 7 nM; mean +/- SEM, n = 9). A transient increase in intracellular calcium (typically up to 400-450 nM) occurred within 1 min of rhuZP3 addition and was followed by sustained lower values of calcium (200-400 nM). These responses were dependent on the amount of rhuZP3. This is the first report of zona protein-induced changes in intracellular calcium levels in human spermatozoa. The results support the premise that ZP3 is an agonist of the human sperm AR and that rhuZP3 generated in a eukaryotic cell is effective in this respect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9239670     DOI: 10.1093/molehr/2.8.583

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

1.  Physiological induction of the acrosome reaction in human sperm: validation of a microassay using minimal volumes of solubilized, homologous zona pellucida.

Authors:  D R Franken; H S Bastiaan; S C Oehninger
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

2.  Physiological induction of the acrosome reaction in human sperm: validation of a microassay using minimal volumes of solubilized, homologous zona pellucida.

Authors:  D R Franken; H S Bastiaan; S C Oehninger
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

3.  No evidence for killer sperm or other selective interactions between human spermatozoa in ejaculates of different males in vitro.

Authors:  H D Moore; M Martin; T R Birkhead
Journal:  Proc Biol Sci       Date:  1999-12-07       Impact factor: 5.349

4.  Zona pellucida from fertilised human oocytes induces a voltage-dependent calcium influx and the acrosome reaction in spermatozoa, but cannot be penetrated by sperm.

Authors:  Catherine Patrat; Jana Auer; Patricia Fauque; Roger L Leandri; Pierre Jouannet; Catherine Serres
Journal:  BMC Dev Biol       Date:  2006-12-05       Impact factor: 1.978

5.  Use of both cumulus cells' transcriptomic markers and zona pellucida birefringence to select developmentally competent oocytes in human assisted reproductive technologies.

Authors:  Mourad Assidi; Markus Montag; Marc-André Sirard
Journal:  BMC Genomics       Date:  2015-01-15       Impact factor: 3.969

Review 6.  Hemizona assay and sperm penetration assay in the prediction of IVF outcome: a systematic review.

Authors:  Paraskevi Vogiatzi; Charalampos Chrelias; David J Cahill; Maria Creatsa; Nikos Vrachnis; Zoe Iliodromiti; Demetrios Kassanos; Charalampos Siristatidis
Journal:  Biomed Res Int       Date:  2013-10-21       Impact factor: 3.411

7.  MAIA, Fc receptor-like 3, supersedes JUNO as IZUMO1 receptor during human fertilization.

Authors:  Jana Vondrakova; Michaela Frolikova; Lukas Ded; Jiri Cerny; Pavla Postlerova; Veronika Palenikova; Ondrej Simonik; Zuzana Nahacka; Krystof Basus; Eliska Valaskova; Radek Machan; Allan Pacey; Zuzana Holubcova; Pavel Koubek; Zuzana Ezrova; Soojin Park; Ruiwu Liu; Raghavendran Partha; Nathan Clark; Jiri Neuzil; Masahito Ikawa; Kent Erickson; Kit S Lam; Harry Moore; Katerina Komrskova
Journal:  Sci Adv       Date:  2022-09-07       Impact factor: 14.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.